Lisa M Barroilhet

10PUBLICATIONS
68CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 18, 2026
An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.

|May 12, 2026
Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis.

|Dec 30, 2025
Early Detection and Prevention of Ovarian Cancer.

Lauren Montemorano, Laura Huffman, Lisa Barroilhet

|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Oct 06, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Britt K Erickson, Howard Bailey, Rebecca C Arend

|Oct 08, 2024
The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate.

Luyao Shen, Elizabeth A Sadowski, Akshya Gupta

Pageof 2

Frequent Collaborators

4 joint publications

Akshya Gupta

4 joint publications

Priyanka Jha

4 joint publications

Elizabeth Sadowski

3 joint publications

Yang Guo